speb/financial-data huggingface dataset:
LUN.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 587600000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 6856900000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 6856900000.00
LUN.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: 631000000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -204500000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 22800000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 22800000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Investments And Advances: 22800000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 22800000.00
LUN.TO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 10200000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 3400000.00
LUN.TO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 1714900000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 267300000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 166900000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 166900000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Long Term Debt: 56300000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 56300000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 223200000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 223200000.00
LUN.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 1714900000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 267300000.00
LUN.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -3299800000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -434800000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Long Term Provisions: 276100000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 276100000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 3775700000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 3775700000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Minority Interest: 1326300000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Minority Interest: 1326300000.00
LUN.TO income_statement (annual, 2025-12-31) — Minority Interests: -370500000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Minority Interests: -252400000.00
LUN.TO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 1393400000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
LUN.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -143500000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -42600000.00
LUN.TO cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 13400000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 14400000.00
LUN.TO income_statement (annual, 2025-12-31) — Net Income: 1283000000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Net Income: 767300000.00
LUN.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 1283000000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 767300000.00
LUN.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 1417700000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 892200000.00
LUN.TO income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 235800000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 127500000.00
LUN.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1283000000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 767300000.00
LUN.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1047200000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 639800000.00
LUN.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 1417700000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 892200000.00
LUN.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 1653500000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 1019700000.00
LUN.TO income_statement (annual, 2025-12-31) — Net Interest Income: -75000000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -8800000.00
LUN.TO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -5000000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -5000000.00
LUN.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -1584900000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -167500000.00
LUN.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -1584900000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -167500000.00
LUN.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -75000000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -8800000.00
LUN.TO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -41300000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 54200000.00
LUN.TO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -11200000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 4000000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Net PPE: 7009300000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 7009300000.00
LUN.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -684600000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -187300000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 6458400000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 6458400000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 719600000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 719600000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 1015800000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 1015800000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 404200000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 404200000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 719600000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 719600000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 611600000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 611600000.00
LUN.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: 1858600000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 601400000.00
LUN.TO income_statement (annual, 2025-12-31) — Normalized Income: 1067005000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 671250000.00
LUN.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 1342600000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 560900000.00
LUN.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: 13400000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 14400000.00
LUN.TO income_statement (annual, 2025-12-31) — Operating Income: 1275100000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Operating Income: 445000000.00
LUN.TO income_statement (annual, 2025-12-31) — Operating Revenue: 3723400000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 975600000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 854347591.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 854347591.00
LUN.TO cash_flow (annual, 2025-12-31) — Other Cash Adjustment Outside Changein Cash: -22000000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Other Current Assets: 53600000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 53600000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 180800000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 180800000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 169800000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 169800000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -23200000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -23200000.00
LUN.TO income_statement (annual, 2025-12-31) — Other Gand A: 63900000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Other Gand A: 12800000.00
LUN.TO income_statement (annual, 2025-12-31) — Other Income Expense: -52400000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: -33300000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 27100000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 27100000.00
LUN.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 14300000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 8500000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 871200000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 871200000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 118900000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 118900000.00
LUN.TO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -29100000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 3700000.00
LUN.TO income_statement (annual, 2025-12-31) — Other Operating Expenses: 53600000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 6900000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Other Payable: 105700000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Other Payable: 105700000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Other Receivables: 60000000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 60000000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 8100000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 8100000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Payables: 544400000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Payables: 544400000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 544400000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 544400000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Prepaid Assets: 22300000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 22300000.00
LUN.TO income_statement (annual, 2025-12-31) — Pretax Income: 1147700000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 402900000.00
LUN.TO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
LUN.TO cash_flow (annual, 2025-12-31) — Purchase Of Business: -610700000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
LUN.TO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -5000000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -5000000.00
LUN.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -684600000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -187300000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Raw Materials: 519900000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Raw Materials: 519900000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Receivables: 829600000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 829600000.00
LUN.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 2655200000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 675000000.00
LUN.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 618900000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 152700000.00
LUN.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -3299800000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -434800000.00
LUN.TO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -153700000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -46000000.00
LUN.TO income_statement (annual, 2025-12-31) — Research And Development: 5400000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: 1270200000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 1270200000.00
LUN.TO cash_flow (annual, 2025-12-31) — Sale Of Business: 2004100000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
LUN.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 63900000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 12800000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Share Issued: 854347591.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 854347591.00
LUN.TO income_statement (annual, 2025-12-31) — Special Income Charges: -17900000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Special Income Charges: -20900000.00
LUN.TO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 12400000.00
LUN.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 3000000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 6619800000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 6619800000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 6458400000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 6458400000.00
LUN.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -3495000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -5550000.00
LUN.TO income_statement (annual, 2025-12-31) — Tax Provision: -270000000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Tax Provision: -489300000.00
LUN.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
LUN.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
LUN.TO balance_sheet (annual, 2025-12-31) — Taxes Receivable: 96000000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 96000000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Total Assets: 10820600000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 10820600000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 6676100000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 6676100000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Total Debt: 449600000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 449600000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 7946100000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 7946100000.00
LUN.TO income_statement (annual, 2025-12-31) — Total Expenses: 2778100000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 700100000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 2874500000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 2874500000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 8784300000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 8784300000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1634000000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1634000000.00
LUN.TO income_statement (annual, 2025-12-31) — Total Other Finance Cost: 20900000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 2600000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Total Tax Payable: 75700000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 75700000.00
LUN.TO income_statement (annual, 2025-12-31) — Total Unusual Items: -23300000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: -37000000.00
LUN.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -23300000.00
LUN.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -37000000.00
LUN.TO balance_sheet (annual, 2025-12-31) — Working Capital: 795800000.00
LUN.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 795800000.00
LUN.TO income_statement (annual, 2025-12-31) — Write Off: 0.00
LUN.TO income_statement (quarterly, 2025-12-31) — Write Off: 0.00
LUN.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 33700000.00
LUN.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 1158800000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 367200000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 664600000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -3663600000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 50500000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 0.00
LUN.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 855930125.00
LUN.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.33
LUN.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 318200000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -182600000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 209200000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 5320900000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 565400000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 565400000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -60000000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -64900000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -179900000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 493700000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Cash From Discontinued Financing Activities: 0.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Cash From Discontinued Investing Activities: 0.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Cash From Discontinued Operating Activities: -1800000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Change In Inventory: -17100000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Change In Payable: 41400000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 41400000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: 3600000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 27900000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 3600000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 247100000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 5320900000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -60000000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 6851500000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -40200000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 2928000000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 621300000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 2060600000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 50900000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 181800000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 250800000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 240800000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1141400000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Current Provisions: 52100000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -66100000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Deferred Tax: -66100000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 134300000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 860831237.00
LUN.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.33
LUN.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 281400000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 17200000.00
LUN.TO income_statement (quarterly, 2026-03-31) — EBIT: 481400000.00
LUN.TO income_statement (quarterly, 2026-03-31) — EBITDA: 615700000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 2900000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -2900000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 100000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 565400000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -64900000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Finished Goods: 58800000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 309300000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 0.00
LUN.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -19300000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -23100000.00
LUN.TO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 17300000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Goodwill: 134300000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 159700000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 10688700000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 537500000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 4000000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 94900000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 133300000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 7200000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 7200000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Interest Income: 2900000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 2900000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Interest Paid Cff: -6900000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Interest Received Cfi: 2900000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 586400000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 7022600000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -179900000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 108300000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Investmentsin Associatesat Cost: 108300000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 219500000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 158300000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 171100000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 329400000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 219500000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -157600000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 108300000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 236800000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 3806300000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Minority Interest: 1372900000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Minority Interests: -106500000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 2300000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -40200000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 20000000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Net Income: 281400000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 281400000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 387000000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: 900000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 281400000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 280500000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 387000000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 387900000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -7000000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 61900000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 61900000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -7000000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -24500000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -2500000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 7025100000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -182600000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 6691800000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 710200000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 922000000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 382100000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 710200000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 539900000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 635000000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 296250948.97
LUN.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 491900000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 17100000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Operating Income: 503800000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 1173500000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 855359839.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 0.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 65700000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 47100000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -23100000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Other Gand A: 17300000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: -22600000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 25400000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -9700000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 913600000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 123500000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -6200000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 16400000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Other Payable: 91900000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Other Receivables: 64500000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Payables: 609600000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 609600000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 26000000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 474200000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 4800000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 0.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -182600000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Raw Materials: 527600000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 813100000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 621300000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 134300000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -157600000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -40200000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 1503200000.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Sale Of Business: 2300000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 17300000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 855359839.00
LUN.TO income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
LUN.TO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 3200000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 6851500000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 6691800000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -3549051.03
LUN.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 87200000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.18
LUN.TO balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 84000000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 10977500000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 7022600000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 511200000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 8224400000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 655000000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 2753100000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 8916900000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1611700000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 2700000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 133300000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: -19300000.00
LUN.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -19300000.00
LUN.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 919200000.00
LUNG balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 10941000.00
LUNG cash_flow (annual, 2021-12-31) — Common Stock Issuance: 0.00
LUNG balance_sheet (annual, 2021-12-31) — Finished Goods: 12029000.00
LUNG balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 10941000.00
LUNG balance_sheet (annual, 2021-12-31) — Investments And Advances: 10941000.00
LUNG cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 0.00
LUNG cash_flow (annual, 2021-12-31) — Issuance Of Debt: 0.00
LUNG cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
LUNG cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 0.00
LUNG cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -41000.00
LUNG balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 277000.00
LUNG balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 179000.00
LUNG balance_sheet (annual, 2021-12-31) — Raw Materials: 3738000.00
LUNG balance_sheet (annual, 2021-12-31) — Work In Process: 518000.00
LUNG income_statement (annual, 2022-12-31) — +Operating Expense: 98502000.00
LUNG income_statement (annual, 2022-12-31) — +Total Revenue: 53662000.00
LUNG balance_sheet (annual, 2022-12-31) — Accounts Payable: 1758000.00
LUNG balance_sheet (annual, 2022-12-31) — Accounts Receivable: 8677000.00
LUNG balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -3556000.00
LUNG balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 502712000.00
LUNG balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -100000.00
LUNG cash_flow (annual, 2022-12-31) — Amortization Of Securities: -204000.00
LUNG cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 485000.00
LUNG balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 5924000.00
LUNG income_statement (annual, 2022-12-31) — Basic Average Shares: 37096541.00
LUNG income_statement (annual, 2022-12-31) — Basic EPS: -1.59
LUNG cash_flow (annual, 2022-12-31) — Beginning Cash Position: 148711000.00
LUNG cash_flow (annual, 2022-12-31) — Capital Expenditure: -1318000.00
LUNG balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 7078000.00
LUNG balance_sheet (annual, 2022-12-31) — Capital Stock: 38000.00
LUNG balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 101736000.00
LUNG balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 141138000.00
LUNG balance_sheet (annual, 2022-12-31) — Cash Equivalents: 4647000.00
LUNG balance_sheet (annual, 2022-12-31) — Cash Financial: 97089000.00
LUNG cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 2419000.00
LUNG cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -4225000.00
LUNG cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -45083000.00
LUNG cash_flow (annual, 2022-12-31) — Change In Account Payable: 247000.00
LUNG cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 149000.00
LUNG cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: -124000.00
LUNG cash_flow (annual, 2022-12-31) — Change In Inventory: -3638000.00
LUNG cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -49000.00
LUNG cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -2197000.00
LUNG cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 8000.00
LUNG cash_flow (annual, 2022-12-31) — Change In Payable: 123000.00
LUNG cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 272000.00
LUNG cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 780000.00
LUNG cash_flow (annual, 2022-12-31) — Change In Receivables: -2190000.00
LUNG cash_flow (annual, 2022-12-31) — Change In Tax Payable: -124000.00
LUNG cash_flow (annual, 2022-12-31) — Change In Working Capital: -7014000.00
LUNG cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -2190000.00
LUNG cash_flow (annual, 2022-12-31) — Changes In Cash: -46889000.00
LUNG balance_sheet (annual, 2022-12-31) — Common Stock: 38000.00
LUNG balance_sheet (annual, 2022-12-31) — Common Stock Equity: 154007000.00
LUNG balance_sheet (annual, 2022-12-31) — Construction In Progress: 1825000.00
LUNG income_statement (annual, 2022-12-31) — Cost Of Revenue: 13797000.00
LUNG balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 7676000.00
LUNG balance_sheet (annual, 2022-12-31) — Current Assets: 168953000.00
LUNG balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 3229000.00
LUNG balance_sheet (annual, 2022-12-31) — Current Debt: 90000.00
LUNG balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 3319000.00
LUNG balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 120000.00
LUNG balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 120000.00
LUNG balance_sheet (annual, 2022-12-31) — Current Liabilities: 18492000.00
LUNG cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 1513000.00
LUNG cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1513000.00
LUNG income_statement (annual, 2022-12-31) — Diluted Average Shares: 37096541.00
LUNG income_statement (annual, 2022-12-31) — Diluted EPS: -1.59
LUNG income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -58923000.00
LUNG income_statement (annual, 2022-12-31) — EBIT: -57504000.00
LUNG income_statement (annual, 2022-12-31) — EBITDA: -55991000.00
LUNG cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 145000.00
LUNG cash_flow (annual, 2022-12-31) — End Cash Position: 101967000.00
LUNG cash_flow (annual, 2022-12-31) — Financing Cash Flow: 2419000.00
LUNG cash_flow (annual, 2022-12-31) — Free Cash Flow: -46401000.00
LUNG cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 7000.00
LUNG balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 1575000.00
LUNG balance_sheet (annual, 2022-12-31) — Goodwill: 2333000.00
LUNG balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 2487000.00
LUNG balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 8777000.00
LUNG balance_sheet (annual, 2022-12-31) — Gross PPE: 14056000.00
LUNG income_statement (annual, 2022-12-31) — Gross Profit: 39865000.00
LUNG cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 398000.00
LUNG balance_sheet (annual, 2022-12-31) — Income Tax Payable: 19000.00
LUNG income_statement (annual, 2022-12-31) — Interest Expense: 1066000.00
LUNG income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 1066000.00
LUNG income_statement (annual, 2022-12-31) — Interest Income: 1529000.00
LUNG income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1529000.00
LUNG cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 847000.00
LUNG balance_sheet (annual, 2022-12-31) — Inventory: 14564000.00
LUNG balance_sheet (annual, 2022-12-31) — Invested Capital: 171331000.00
LUNG cash_flow (annual, 2022-12-31) — Investing Cash Flow: -4225000.00
LUNG balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 5924000.00
LUNG balance_sheet (annual, 2022-12-31) — Investments And Advances: 5924000.00
LUNG cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
LUNG balance_sheet (annual, 2022-12-31) — Leases: 2277000.00
LUNG balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 3849000.00
LUNG balance_sheet (annual, 2022-12-31) — Long Term Debt: 17234000.00
LUNG balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 21083000.00
LUNG cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
LUNG cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -87000.00
LUNG balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 4148000.00
LUNG income_statement (annual, 2022-12-31) — Net Income: -58923000.00
LUNG income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -58923000.00
LUNG income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -58923000.00
LUNG income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -58923000.00
LUNG income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -58923000.00
LUNG cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -58923000.00
LUNG income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -58923000.00
LUNG income_statement (annual, 2022-12-31) — Net Interest Income: 463000.00
LUNG cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -2907000.00
LUNG cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -87000.00
LUNG cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -87000.00
LUNG income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 463000.00
LUNG cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -53000.00
LUNG balance_sheet (annual, 2022-12-31) — Net PPE: 10500000.00
LUNG cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1318000.00
LUNG balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 151520000.00
LUNG balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 94000.00
LUNG balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 94000.00
LUNG income_statement (annual, 2022-12-31) — Normalized EBITDA: -55991000.00
LUNG income_statement (annual, 2022-12-31) — Normalized Income: -58923000.00
LUNG cash_flow (annual, 2022-12-31) — Operating Cash Flow: -45083000.00
LUNG cash_flow (annual, 2022-12-31) — Operating Gains Losses: 7000.00
LUNG income_statement (annual, 2022-12-31) — Operating Income: -58637000.00
LUNG income_statement (annual, 2022-12-31) — Operating Revenue: 53662000.00
LUNG balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 37555565.00
LUNG balance_sheet (annual, 2022-12-31) — Other Current Assets: 290000.00
LUNG balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 90000.00
LUNG balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 1575000.00
LUNG income_statement (annual, 2022-12-31) — Other Income Expense: -396000.00
LUNG balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 154000.00
LUNG cash_flow (annual, 2022-12-31) — Other Non Cash Items: 2554000.00
LUNG balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 5812000.00
LUNG income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -396000.00
LUNG balance_sheet (annual, 2022-12-31) — Other Properties: 5806000.00
LUNG balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 39402000.00
LUNG balance_sheet (annual, 2022-12-31) — Payables: 2404000.00
LUNG balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 10080000.00
LUNG balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4973000.00
LUNG balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
LUNG balance_sheet (annual, 2022-12-31) — Prepaid Assets: 3451000.00
LUNG income_statement (annual, 2022-12-31) — Pretax Income: -58570000.00
LUNG cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 2559000.00
LUNG balance_sheet (annual, 2022-12-31) — Properties: 0.00
LUNG cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 54000.00
LUNG cash_flow (annual, 2022-12-31) — Purchase Of Investment: -47187000.00
LUNG cash_flow (annual, 2022-12-31) — Purchase Of PPE: -1318000.00
LUNG balance_sheet (annual, 2022-12-31) — Receivables: 9279000.00
LUNG income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 13797000.00
LUNG income_statement (annual, 2022-12-31) — Reconciled Depreciation: 1513000.00
LUNG cash_flow (annual, 2022-12-31) — Repayment Of Debt: -87000.00
LUNG income_statement (annual, 2022-12-31) — Research And Development: 15397000.00
LUNG balance_sheet (annual, 2022-12-31) — Restricted Cash: 231000.00
LUNG balance_sheet (annual, 2022-12-31) — Retained Earnings: -350318000.00
LUNG cash_flow (annual, 2022-12-31) — Sale Of Investment: 44280000.00
LUNG income_statement (annual, 2022-12-31) — Selling General And Administration: 83105000.00
LUNG balance_sheet (annual, 2022-12-31) — Share Issued: 37555565.00
LUNG cash_flow (annual, 2022-12-31) — Stock Based Compensation: 16445000.00
LUNG balance_sheet (annual, 2022-12-31) — Stockholders Equity: 154007000.00
LUNG balance_sheet (annual, 2022-12-31) — Tangible Book Value: 151520000.00
LUNG income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
LUNG income_statement (annual, 2022-12-31) — Tax Provision: 353000.00
LUNG income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
LUNG balance_sheet (annual, 2022-12-31) — Taxes Receivable: 602000.00
LUNG balance_sheet (annual, 2022-12-31) — Total Assets: 193676000.00
LUNG balance_sheet (annual, 2022-12-31) — Total Capitalization: 171241000.00
LUNG balance_sheet (annual, 2022-12-31) — Total Debt: 24402000.00
LUNG balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 154007000.00
LUNG income_statement (annual, 2022-12-31) — Total Expenses: 112299000.00
LUNG balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 39669000.00
LUNG balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 24723000.00
LUNG balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 21177000.00
LUNG income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -58637000.00
LUNG balance_sheet (annual, 2022-12-31) — Total Tax Payable: 646000.00
LUNG balance_sheet (annual, 2022-12-31) — Working Capital: 150461000.00
LUNG income_statement (annual, 2023-12-31) — +Operating Expense: 112687000.00
LUNG income_statement (annual, 2023-12-31) — +Total Revenue: 68675000.00
LUNG balance_sheet (annual, 2023-12-31) — Accounts Payable: 1497000.00
LUNG balance_sheet (annual, 2023-12-31) — Accounts Receivable: 12105000.00
LUNG balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -4855000.00
LUNG balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 526797000.00
LUNG balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
LUNG cash_flow (annual, 2023-12-31) — Amortization Of Securities: -1025000.00
LUNG cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 507000.00
LUNG balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 14390000.00
LUNG income_statement (annual, 2023-12-31) — Basic Average Shares: 37974567.00
LUNG income_statement (annual, 2023-12-31) — Basic EPS: -1.60
LUNG cash_flow (annual, 2023-12-31) — Beginning Cash Position: 101967000.00
LUNG cash_flow (annual, 2023-12-31) — Capital Expenditure: -807000.00
LUNG balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 4180000.00
LUNG balance_sheet (annual, 2023-12-31) — Capital Stock: 39000.00
LUNG balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 83547000.00
LUNG balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 117102000.00
LUNG balance_sheet (annual, 2023-12-31) — Cash Equivalents: 25129000.00
LUNG balance_sheet (annual, 2023-12-31) — Cash Financial: 58418000.00
LUNG cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 21400000.00
LUNG cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -2007000.00
LUNG cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -37610000.00
LUNG cash_flow (annual, 2023-12-31) — Change In Account Payable: -345000.00
LUNG cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 3176000.00
LUNG cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: 68000.00
LUNG cash_flow (annual, 2023-12-31) — Change In Inventory: 918000.00
LUNG cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -36000.00
LUNG cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -3182000.00
LUNG cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 4000.00
LUNG cash_flow (annual, 2023-12-31) — Change In Payable: -277000.00
LUNG cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 2899000.00
LUNG cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -57000.00
LUNG cash_flow (annual, 2023-12-31) — Change In Receivables: -3104000.00
LUNG cash_flow (annual, 2023-12-31) — Change In Tax Payable: 68000.00
LUNG cash_flow (annual, 2023-12-31) — Change In Working Capital: -2558000.00
LUNG cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -3104000.00